15324 Long-term management of moderate to severe plaque psoriasis: Maintenance of treatment success following cessation of fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in patients with baseline body surface area of 6%-12%
Gold, Linda Stein, Weiss, Jonathan S., Green, Lawrence J., Kircik, Leon, PharMD, Tina Lin, Harris, SusanVolume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.231
Date:
December, 2020
File:
PDF, 861 KB
2020